Description
+ Include: 13 videos + 1 pdf, size: 3.01 GB
+ Target Audience: oncologist
+ Sample video: contact me for sample video
+ Information:
The goals of this activity are to help participants examine synthesized data from completed studies, discuss the novel investigational agents available in ongoing clinical trials, and describe the rationale for and results of studies that include novel agents targeting oncogenic relevant molecular alterations for the treatment of patients with advanced cancer. This knowledge will enable them to appropriately utilize new treatments available to cancer patients, provide support for current and future oncology clinical trials, and become stronger leaders in the area of oncology research. In sum, this program will convey information on how to better implement precision medicine in oncologic care, leading to better outcomes for patients suffering from cancer.
Target Audience
Learning Objectives
At the conclusion of this activity, participants will be able to:
- State the clinical effects of novel experimental agents; including but not limited to immunotherapeutic approaches other than PD1 and CTLA4 checkpoint inhibitors, nuclear hormone receptor modulating agents, and epigenetic targeted drugs;
- Cite the relevant pharmacologic and biologic effects of novel anti-cancer agents through the use of blood and tissue samples as well as standard and novel imaging approaches including novel PET tracer imaging and circulating tumor DNA assays;
- Identify how to assess patient suitability for participation in ongoing and upcoming cancer clinical trials and projects;
- Discuss advances in the use of systemic therapies for cancer; including those targeting specific molecular alterations such as DNA repair mutations, specific chromosomal translocations, and tyrosine kinase mutations.
+ Topics:
Agenda.pdf
Session 1 Age of Cellular Therapy at University of Chicago.mp4
Session 1 Developmental Therapeutics for Biliary Tract Cancers.mp4
Session 1 Emerging strategies for the treatment of NSCLC.mp4
Session 1 Emerging treatment paradigms in head and neck cancer.mp4
Session 1 Myeloma 2022 – Challenges and Path Forward.mp4
Session 1 T cell adoptive therapy for solid tumors.mp4
Session 1 Targeted Progress in the Treatment of Gynecologic Malignancies.mp4
Session 2 Enhancing access to clinical trials for adolescents and young adults with cancer.mp4
Session 2 Integration of Radiotherapy into Developmental Therapeutics- What we have learned.mp4
Session 2 New Developments in Precision Medicine for CU Malignancies.mp4
Session 2 Personalizing Therapeutic Approaches in Leukemia and Myeloid Malignancies.mp4
Session 2 Recent Advances in Pharmacogenomic Applications to Cancer Care.mp4
Session 2 Update on immunotherapy efforts in lymphoma at U of C.mp4
Reviews
There are no reviews yet.